All data are based on the daily closing price as of September 28, 2026
m
Menicon
7780.TSE
11.21 USD
0.03
+0.27%
Overview
Last close
11.21 usd
Market cap
832.16M usd
52 week high
13.22 usd
52 week low
6.94 usd
Target price
14.33 usd
Valuation
P/E
22.4228
Forward P/E
N/A
Price/Sales
1.0255
Price/Book Value
1.3603
Enterprise Value
1.14B usd
EV/Revenue
1.4197
EV/EBITDA
8.7044
Key financials
Revenue TTM
813.77M usd
Gross Profit TTM
439.97M usd
EBITDA TTM
147.25M usd
Earnings per Share
0.5 usd
Dividend
0.18 usd
Total assets
1.25B usd
Net debt
292.07M usd
About
Menicon Co., Ltd. produces and sells contact lenses in Japan and internationally. It operates through Vision Care Business and Others segments. The company offers disposable lenses, MTO specialty lenses, myopia management products, and lens care products. It also engages in the manufacture and sale of medical instruments; sale of medical supplies; research and development of intraocular lenses; healthcare business comprising products utilizing self-assembling peptide gel technology and bone graft substitute materials; life care business consisting of turf grass for green infrastructure; veterinary medical business, such as the sale of supplements for dogs and cats through animal hospitals and veterinary pharmaceutical wholesalers; and food business, including the sale and import/export of agricultural and marine products. The company sells its products to hospitals, ophthalmological clinics, optical shops, pharmaceutical wholesalers, and distributors. It exports its products to approximately 80 countries. Menicon Co., Ltd. was incorporated in 1943 and is headquartered in Nagoya, Japan.